Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperkalemia Registry An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure

NCT05297409 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05297409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05297409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperkalemia Registry An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 21, 2022
Completion date
August 28, 2024
Enrollment
352 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia